Etonogestrel Implant: Efficacy, Timing, and Drug Interaction Guidelines

Contraceptive Effectiveness

• The implant demonstrates exceptional effectiveness, with a pregnancy‑failure rate of less than 0.05 % over the approved 3‑year duration, making it one of the most reliable reversible contraceptive methods available. 1

Timing and Backup Contraception

• When the implant is placed within the first 5 days of menstrual bleeding, ovulation suppression occurs immediately, so no additional (backup) contraception is required. (CDC MMWR recommendation) 2
• If insertion occurs 6 days or more after the start of menstrual bleeding, users should employ backup contraception (e.g., condoms or abstinence) for at least 7 days to ensure full contraceptive protection. (CDC MMWR recommendation) 2

Drug Interactions

• Hepatic enzyme‑inducing agents (e.g., efavirenz, nevirapine, most protease inhibitors) increase the metabolism of etonogestrel, potentially reducing its contraceptive effectiveness; alternative or additional contraceptive methods are advised. (Praxis Medical Insights) 1
• Standard oral antibiotics do not diminish the effectiveness of the etonogestrel implant, unlike their impact on combined oral contraceptives. (Praxis Medical Insights) 1

Bleeding Patterns and Counseling for Nexplanon Users

Adverse Effects and Patient Counseling

• In women using the Nexplanon (etonogestrel) implant, amenorrhea occurs in about 22 % and irregular bleeding (infrequent spotting) in roughly 34 % of users; these bleeding patterns are unchanged when semaglutide (Ozempic) is taken concurrently, indicating no interaction affecting menstrual side effects. 3, 4, 5